Genentech reports positive Phase II results for enicepatide in type 2 diabetes

Pharming reports positive Phase II data for leniolisib in primary immunodeficiencies

Insmed's ARIKAYCE sNDA granted priority review by FDA

Precigen announces FDA platform technology designation for AdenoVerse

Enhertu recommended for EU approval in early HER2-positive breast cancer

PureTech receives FDA Fast Track designation for LYT-200 in HR-MDS

CHMP recommends EU approval of Klygefa for generalised myasthenia gravis

Zealand Pharma's Zeydovio (glepaglutide) receives positive CHMP opinion for short bowel syndrome treatment

Velocity Clinical Research appoints new CEO

Ipsen appoints new board director

Coiled Therapeutics completes enrolment in two AO-252 formulation cohorts

MaaT Pharma outlines potential Phase 3 development plan for MaaT013 after CHMP negative opinion

Kemp Proteins partners with NeuImmune to advance precision protein production

Genentech's Lunsumio regimen improves progression-free survival in Phase III follicular lymphoma study

Bayer's Kerendia wins FDA approval for chronic kidney disease associated with type 1 diabetes